Literature DB >> 37747

Calcium: pacesetting the periodic psychoses.

J S Carman, R J Wyatt.   

Abstract

In this double-blind study dihydrotachysterol (DHT) was given orally to eight psychotic patients; in each case marked increases in psychosis and agitation accompanied increases in serum calcium and phosphorus within two weeks after active drug was substituted for placebo. In the three patients whose psychoses exhibited periodic spontaneous exacerbations, the agitated episodes grew more severe. Serum creatine phosphokinase (CPK) increased in all but one patient. By contrast, when three periodically psychotic patients received synthetic salmon calcitonin (SCT), the severity and frequency of agitated episodes decreased while CSF calcium increased in all three. These data support the hypothesis that the observed abrupt increases in serum calcium and phosphorus might cause the opposite CSF calcium shifts, the behavioral agitation and the increases in serum CPK frequently noted during acute psychosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37747     DOI: 10.1176/ajp.136.8.1035

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

Review 1.  Evaluation and treatment of children and adolescents with psychotic symptoms.

Authors:  Sibel Algon; James Yi; Monica E Calkins; Christian Kohler; Karin E Borgmann-Winter
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

2.  Regional calcium levels in rat and mouse brain: automated fluorimetric assay and effects of centrally acting drugs.

Authors:  J Korf; F H Zoethout; F Postema
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 3.  Calcium channel blockers for antipsychotic-induced tardive dyskinesia.

Authors:  Adib Essali; Karla Soares-Weiser; Hanna Bergman; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2018-03-26

4.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.